IPO Guru
Bajaj
Listed Mainboard

Concord Biotech IPO Subscription Status

Concord Biotech IPO was subscribed 24.87 times when bidding closed on 8 Aug 2023: QIB 67.67x, NII 16.99x, Retail 3.78x.

The Concord Biotech IPO has been subscribed 24.87x times overall. Retail investors have shown interest with bids for 3.78x the shares available. The Non-Institutional Investor (NII) category has been subscribed 16.99x. Within NII, Big HNI (B-HNI) subscribed 19.3x and Small HNI (S-HNI) subscribed 12.37x. Qualified Institutional Buyers (QIBs) have subscribed 67.67x. Data last updated on 10 Nov, 06:04 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 04 Aug, 2023 and closes on 08 Aug, 2023. The shares are expected to list on stock exchanges on 18 Aug, 2023.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 10 Nov 2026, 06:04 PM
Category Bid details Times
QIB - of - - 67.67x
NII - of - - 16.99x
bHNI — bid amount above ₹10 Lakh
- - 19.3
sHNI — bid amount ₹2–10 Lakh
- - 12.37
Retail - of - - 3.78x
Employee - of - - 24.48x
TOTAL - - 24.87x
Advertisement

Concord Biotech IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
1 out of 4
~26.5% chance per PAN — based on 3.78x subscription. Winners get exactly 1 lot (₹14,820) by SEBI lottery, however many lots you bid.
Small HNI (₹2–10 L)
1 out of 12
~8.1% chance — based on 12.37x subscription. Lottery allots the minimum S-HNI application of 14 lots (₹2.1 L) per winner; bidding bigger doesn't improve odds.
Big HNI (above ₹10 L)
1 out of 18
~5.2% chance — based on 19.3x subscription. Lottery allots the minimum NII application of 14 lots (₹2.1 L) per winner, the same as S-HNI; any shares left over are allotted proportionately.
QIB (institutions)
67.67x
Proportionate allotment — at 67.67x, institutions receive ~1.5% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 26.5% for a single lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 67.67x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.

Date Total
08 Aug 2023
Day 3
24.87x ▼
QIB67.67x BHNI19.3x SHNI12.37x Retail3.78x Employee24.48x
07 Aug 2023
Day 2
2.72x ▼
QIB1.61x BHNI5.12x SHNI5.42x Retail2.26x Employee15.68x
04 Aug 2023
Day 1
0.58x ▼
QIB0.01x BHNI0.96x SHNI1.11x Retail0.72x Employee5.73x

Concord Biotech IPO dates

From the bidding window to listing. Today is 17 November.

Key dates Listed
  1. Open 04 Aug 2023
  2. Close 08 Aug 2023
  3. Allotment 11 Aug 2023
  4. Refund/credit 14 Aug 2023
  5. Listing 18 Aug 2023

Anchor investor allocation

Shares allotted to anchor investors the working day before the issue opened.

Anchor Investor Amt (₹ cr.) % Allocated
GOVERNMENT OF SINGAPORE ₹24.99 Cr 5.37%
ABU DHABI INVESTMENT AUTHORITY - STABLE ₹22.49 Cr 4.84%
GOVERNMENT PENSION FUND GLOBAL ₹22.49 Cr 4.84%
POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUND ₹22.49 Cr 4.84%
ASHOKA INDIA OPPORTUNITIES FUND ₹22.49 Cr 4.84%
HSBC INDIAN EQUITY MOTHER FUND ₹22.49 Cr 4.84%
WF ASIAN RECONNAISSANCE FUND LIMITED ₹22.49 Cr 4.84%
AMUNDI FUNDS NEW SILK ROAD ₹22.49 Cr 4.84%
THE PRUDENTIAL ASSURANCE COMPANY LIMITED ₹22.49 Cr 4.84%
PINEBRIDGE GLOBAL FUNDS - PINEBRIDGE INDIA EQUITY FUND ₹22.49 Cr 4.84%
MIRAE ASSET HEALTHCARE FUND ₹22.49 Cr 4.84%
DSP HEALTHCARE FUND ₹22.49 Cr 4.84%
FRANKLIN INDIA SMALLER COMPANIES FUND ₹17.49 Cr 3.76%
MOTILAL OSWAL LARGE AND MIDCAP FUND ₹14.19 Cr 3.05%
SBI LIFE INSURANCE COMPANY LIMITED ₹14.19 Cr 3.05%
BARODA BNP PARIBAS LARGE & MID CAP FUND ₹14.19 Cr 3.05%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND ₹14.05 Cr 3.02%
UTI - HEALTHCARE FUND ₹11.24 Cr 2.42%
UTI SMALL CAP FUND ₹11.24 Cr 2.42%
ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITED ₹10.00 Cr 2.15%
BAJAJ ALLIANZ LIFE INSURANCE COMPANY LTD ₹10.00 Cr 2.15%
INVESCO INDIA FLEXI CAP FUND ₹10.00 Cr 2.15%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND ₹8.43 Cr 1.81%
BANDHAN MIDCAP FUND ₹8.19 Cr 1.76%
BANDHAN EMERGING BUSINESSES FUND ₹6.00 Cr 1.29%
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS RECENTLY LISTED IPO FUND ₹5.00 Cr 1.08%
FRANKLIN INDIA OPPORTUNITIES FUND ₹5.00 Cr 1.07%
TATA AIA LIFE INSURANCE COMPANY LIMITED A/C EMERGING OPPORTUNITIES FUND (ULIF 064 12/09/22 EOF 110) ₹4.50 Cr 0.97%
MAX LIFE INSURANCE CO. LTD. A/C DIVERSIFIED EQUITY FUND (ULIF02201/01/20LIFEDIVEQF104) ₹4.45 Cr 0.96%
INVESCO INDIA EQUITY & BOND FUND ₹4.19 Cr 0.90%
EDELWEISS FOCUSED EQUITY FUND ₹2.69 Cr 0.58%
TATA AIA LIFE INSURANCE COMPANY LIMITED A/C SMALL CAP DISCOVERY FUND (ULIF 071 22/05/23 SCF 110) ₹2.50 Cr 0.54%
MAX LIFE INSURANCE CO. LTD A/C ULIF01213/08/07PENSGRWSUP104 - PENSION GROWTH SUPER FUND ₹2.40 Cr 0.52%
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS AGGRESSIVE HYBRID FUND ₹2.09 Cr 0.45%
TATA AIA LIFE INSURANCE COMPANY LIMITED A/C LIFE WHOLE LIFE STABLE GROWTH FUND ULIF 011 04/01/07 WLS 110 ₹2.00 Cr 0.43%
MAX LIFE INSURANCE CO. LTD. A/C SUSTAINABLE EQUITY FUND - ULIF02505/10/21 SUSTAINEQU104 ₹1.95 Cr 0.42%
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS SMALL CAP FUND ₹1.80 Cr 0.39%
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS LARGE & MID CAP FUND ₹1.30 Cr 0.28%
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS LONG TERM EQUITY FUND ₹1.30 Cr 0.28%
MAX LIFE INSURANCE CO. LTD. - PURE GROWTH FUND ₹1.20 Cr 0.26%
TATA AIA LIFE INSURANCE COMPANY LIMITED A/C DYNAMIC ADVANTAGE EQUITY FUND (ULIF 066 12/0/22 DAF 110) ₹1.00 Cr 0.22%
TOTAL ₹464.96 Cr 100.04%
View allotment letter PDF →

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Concord Biotech IPO?

As of IPO close date (08 Aug, 2023), the Concord Biotech IPO is subscribed 24.87x times. Retail category is 3.78x, and NII is 16.99x subscribed.

When is the allotment date for Concord Biotech IPO?

The allotment for Concord Biotech IPO is expected to be finalized on 11 August, 2023.

What is the GMP of Concord Biotech?

The Grey Market Premium (GMP) for Concord Biotech is currently ₹67.67, indicating a potential listing gain of 9%.

When will Concord Biotech IPO list on the stock market?

Concord Biotech is scheduled to list on BSE and NSE on 18 August, 2023.

What are the chances of getting allotment in Concord Biotech IPO?

The retail category is oversubscribed at 3.78x, meaning allotment is by lottery. Statistically, approximately 1 in 4 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 67.67x mean for Concord Biotech IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 67.67x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Concord Biotech IPO allotment status?

After the allotment date (11 Aug, 2023), you can check your Concord Biotech IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Concord Biotech IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
24.87x
QIB
67.67x
NII
16.99x
bHNI
19.3x
sHNI
12.37x
Retail
3.78x
Full IPO details
Advertisement